期刊文献+

放射性核素治疗的规范管理与思考 被引量:5

Clinical Management and Thinking of Radionuclide Therapy
下载PDF
导出
摘要 放射性核素治疗是一种特殊的治疗技术,其整个治疗过程都具有放射性。因此,针对该技术的学科建设和临床管理不仅要遵循符合常规医疗管理的通则,同时要注重辐射安全性问题。该文根据相关法规的要求并结合本部门长期实践经验对放射性核素治疗的规范化建设和内部管理基本要求提出相关的意见和建议,着重强调门诊和病房放射性核素治疗的基本原则。 As a special treatment modality, radionuclide therapy is characterized by radioactivity throughout the treatment procedure. Concerning the specific nuclear medicine faculty clinical management of this technology must pay much attention to the radiation safety as well as comply with the conventional requirements of medical management. Based on our long term clinical practice and with reference to relevant roles and regulations, this paper introduces the key issues related with normative internal management for radionuclide therapy and pinpoints on the general principles for the out patients and hospitalized management of radionuclide therapy.
出处 《上海第二医科大学学报》 CSCD 北大核心 2005年第12期1288-1291,共4页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 放射性核素 治疗 管理 病房 门诊 radionuclide treatment management
  • 相关文献

参考文献10

  • 1中华医学会.临床核医学操作规范[M].北京:人民军医出版社,2004.60-62.
  • 2卫生部医政司.核医学诊断与治疗规范[M].北京:科学出版社,1997.93-94.
  • 3.中华人民共和国国家标准临床核医学放射卫生防护标准(GB16360-1996)[S].北京:中国标准出版社,1996..
  • 4.中华人民共和国国家标准电离辐射防护与辐射源安全基本标准(GB 18871-2002)[S].北京:中国标准出版社,2002..
  • 5国家食品药物监督管理局 卫生部 公安局 国家环境保护总局.关于开展换发《放射性药品许可证》工作的通知[S]国食药监安[2003]199号[Z].,2003..
  • 6匡安仁,谭天秩.放射性核素治疗的发展与思考[J].中华核医学杂志,2003,23(6):325-326. 被引量:7
  • 7谭海波,张荣银,刘轶.核医学科病房的建设与管理[J].中华核医学杂志,2004,24(2):124-124. 被引量:16
  • 8Extracts from IAEA's resources manual in nuclear medicine[ J].W J Nucl Med,2003,2(4):324-341.
  • 9Venencia CD,Germanier AG,Bustos SR,et al.Hospital discharge of patients with thyroid carcinoma treated with ^131Ⅰ[ J].J Nucl Med,2002,43 (1):61-65.
  • 10Thompson MA.Radiation safety precaution in the management of the hospitalized ^131Ⅰ therapy patients[ J].J Nucl Med Technol,2001,29(2):61-66.

二级参考文献9

  • 1Wagner HN. Highlights 2002 lecture: reinventing clinical nuclear medicine. J Nucl Med, 2002, 43: 13N-38N.
  • 2Wagner HN. Highlights 2003 lecture: from proof of principle to proof of value. J Nucl Med, 2003, 44: 11N-36N.
  • 3Kraiem Z, Newfield RS. Graves' disease in childhood. J Pediatr Endocrinol Metab, 2001, 14: 229-243.
  • 4Tuttle RM, Becker DV, Hurley JR. Radioiodine treatment of thyroid disease. In: Sandler MD, Coleman RE, Patton JA, et al, eds. Diagnostic nuclear medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins,2003. 655.
  • 5Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in chidren, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab, 1998, 83: 3767-3776.
  • 6Imseis RE, Vanmiddlesworth L, Massie JD, et al. Pretreatment with propylthiouacil but not methimazole reduces the therapeutic efficacy of 131I in hyperthyroidism. J Clin Endocrinol Metab, 1998, 83: 685-687.
  • 7Andrade VA, Gross JL, Maia L. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: oneyear follow-up of a prospective, randomized study. J Clin Endocrinol Metab, 2001, 86: 3488-3493.
  • 8陈文贤,颜兵,董延武,毛正中,陈启.抗甲状腺药物和碘131治疗甲亢的医疗成本分析[J].中国卫生事业管理,1999,15(6):302-305. 被引量:10
  • 9戴为信,胡明明,卓勤俭.2000年300名中国内分泌医师对Graves病治疗的态度调查[J].中华内分泌代谢杂志,2002,18(6):466-467. 被引量:3

共引文献23

同被引文献32

  • 1张干清,张力,王以群.人误屏障分析技术[J].中国安全科学学报,2005,15(3):13-16. 被引量:26
  • 2朱君亚,王华,郑洁,沈霞,向清.JCI患者安全策略及其对医疗实践的启示[J].中国医院,2006,10(4):11-13. 被引量:23
  • 3王光琳,马黎明,李江城,胡燕燕,吴武梅.放射性核素治疗病房的护理体会[J].西南军医,2007,9(3):124-124. 被引量:12
  • 4Fallahi B, Adabi K, Majidi M, et al. Incidence of second primary malignancies during a long-term surveillance of patients with differ- entiated thyroid carcinoma in relation to radioiodine treatment [ J ]. Clin Nucl Med, 2011, 36 (4) : 277-282.
  • 5Cox AE, LeBeau SO. Diagnosis and treatment of differentiated thy- roid carcinoma[ J ]. Radiol Clin North Am, 2011, 49 (3): 453- 462, vi.
  • 6Lyu ZW, Wang PJ. Nuclear Medicine [ M 1. Beijing: Science Press, 2010: 195-196.
  • 7Chen YD, Zhang F, Wu CX, et al. Radiation protection and man- agement in the radionuclide therapy wardI J~. Chin J Nurs, 2014, 49( 5 ) : 574-576.
  • 8Cost-benefit analysis in the optimization of radiation protectionE J 1. Ann ICRP, 1983, 10(2-3): 1-75.
  • 9Optimization and decision-making in radiological protection. A re- port of a Task Group of Committee 4 of the International Commission on Radiolo~ical ProtectionS-J]. Ann ICRP, 1989, 20(1) : 1-60.
  • 10Lu HK, Zhu RS, Yu YL, et al. Clinical management and thinking of radionuclide therapy[ J ]. Acad J Shanghai Sec Med Univ, 2005, 25 (12) : 1288-1291.

引证文献5

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部